News from NYU Langone Health
Inside Dr. Robert Grossman’s Aspirational Tenure As NYU Langone Health CEO. (Becker's Hospital Review)
(8/13) Robert I. Grossman, MD, dean and CEO, is set to retire as CEO of NYU Langone Health and dean of NYU Grossman School of Medicine at the end of August, having transformed the organization from a small regional hospital with $2 billion in revenue in 2007 to a leading academic health system with $14.2 billion in revenue in 2024, and he will assume a new role as executive vice president to the NYU Langone Health board of trustees; his tenure saw major investments in healthcare IT, operational integration, and a shift to an ambulatory care-focused model, and he emphasized, “It’s about excellence, and excellence is cost effective,” while expressing optimism for his successor, Alec Kimmelman, MD, PhD, the Anita Steckler and Joseph Steckler Chair, and professor, Department of Radiation Oncology, Perlmutter Cancer Center, to continue this trajectory.
How US News’ Top Hospitals Fared With CMS Star Ratings. (Becker's Hospital Review)
(8/13) NYU Langone Health received a five-star rating in the CMS’ 2025 Overall Hospital Quality Star Ratings, aligning with its recognition on the U.S. News & World Report’s 2025-26 Honor Roll.
(8/13) NYU Langone Hospital—Long Island was awarded a five-star rating by the Centers for Medicare & Medicaid Services, highlighting its excellence alongside other top-rated hospitals, while NYU Langone Hospital — Suffolk improved its rating from one to two stars. James Iorio, director of media relations for NYU Langone Hospital—Suffolk, said “the hospital has substantially improved patient care’ by reducing average patient stays by more than a day and lowering emergency room wait times by 70%, to an average of less than 10 minutes.”
(8/13) NYU Langone Health ranked No. 1 in the U.S. News & World Report’s 2025-2026 Best Hospitals for Geriatrics, based on patient outcomes, structure, expert opinion, patient experience, and transparency, as announced July 29.
NYU Langone Hospital – Suffolk Completes Several Complex Robotic Surgeries. (News 12-TV Long Island (NY))
Long Island, NY (8/13) The operative team at NYU Langone Hospital–Suffolk recently completed four robotic surgeries, marking a lifesaving milestone as these procedures had never been offered at the facility before; three of these surgeries involved removing cancerous tumors from patients, and the hospital reports that these procedures are part of over 2,000 robotic surgeries performed on campus, with physicians saying that robotic surgeries enable better precision and faster recovery times.
Also reporting is (8/13).
Who’s Snapping Up Physicians? 10 Deals To Know. (Becker's ASC Review)
(8/13) NYU Langone Health and NYU Langone Orthopedics acquired Rothman Orthopaedics of Greater New York, expanding the system’s orthopedic care in New York City.
A Small Change In Your Stride Can Ease Knee Arthritis Pain. (HealthDay)
(8/13) A study published in The Lancet Rheumatology by NYU Langone Health researchers, including Valentina Mazzoli, PhD, assistant professor, Department of Radiology, found that adjusting foot position while walking can reduce knee stress and pain in individuals with osteoarthritis, with Mazzoli stating, “Altogether, our findings suggest that helping patients find their best foot angle to reduce stress on their knees may offer an easy and fairly inexpensive way to address early-stage osteoarthritis.”
(8/13) Dr. Mazzoli added, “These results highlight the importance of personalizing treatment instead of taking a one-size-fits-all approach to osteoarthritis,” noting that while the strategy “may sound challenging, recent advances in detecting the motion of different body parts using artificial intelligence may make it easier and faster than ever before.”
(8/13) also reports.
First Drug To Treat Bronchiectasis Lung Condition Approved By FDA. (HealthDay)
(8/13) The FDA has approved Insmed’s brensocatib (Brinsupri) for non-cystic fibrosis bronchiectasis, a chronic lung condition, with Doreen Addrizzo-Harris, MD, the Fiona and Stanley Druckenmiller Professor of Pulmonary, Critical Care and Sleep Medicine, stating, “For the first time, we have a treatment that directly targets neutrophilic inflammation and addresses a root cause of bronchiectasis exacerbations” adding, “Based on the strength of the data and the impact we’ve seen in patients, I believe this could become the new standard in non-cystic fibrosis bronchiectasis care.”
Also reporting are (8/13) and (8/13).
‘It Comes Down To Participation’: The Best Option For CRC Screening Is The One Patients Use. (Healio)
(8/11) Colonoscopy remains the most sensitive method for colorectal cancer (CRC) screening in the U.S., with a sensitivity of approximately 95%, but its invasiveness and cost are barriers, whereas fecal immunochemical testing (FIT) offers a noninvasive alternative with lower sensitivity and requires annual testing; new stool- and blood-based tests, such as Cologuard and ColoSense, present emerging options with varying sensitivities and adherence challenges, as discussed by experts including Aasma Shaukat, MD, MPH, the Robert M. and Mary H. Glickman Professor of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, professor, Department of Population Health, who said, “There have been several models that have been used to demonstrate the immediate direct and indirect costs, but there are obviously also long-term costs.”
Praxis’ Vormatrigine Shows Significant Ability To Reduce Seizure Incidence In Phase 2 RADIANT Study. (Neurology Live)
(8/13) The phase 2 RADIANT study revealed that Praxis’ vormatrigine significantly reduced seizure frequency in patients with focal onset seizures, with a 56.3% median reduction over an 8-week period; Jacqueline A. French, MD, professor, Department of Neurology, Comprehensive Epilepsy Center, said, “I’m encouraged by the initial results of the RADIANT study and hopeful that, in the future, we may be able to offer patients another effective treatment option.”
Here’s Exactly What To Eat For All-Day Energy. (TIME)
(8/13) Kelly-Marie Andersen, clinical dietitian, recommends eating a balanced breakfast with protein and fiber, noting this “boosts focus, stabilizes blood sugar, and prevents mid-morning crashes,” and suggesting options like eggs, yogurt, oatmeal, or whole-grain toast, while advising against consuming refined carbohydrates like bagels or pastries.
9 Vitamin B6-Rich Foods For Immune System And Metabolism Benefits. (TODAY)
(8/13) Collin J. Popp, PhD, assistant professor, Department of Population Health, recommends consuming vitamin B6-rich foods like chickpeas, tuna, salmon, potatoes, chicken, bananas, beef, bulgur, and winter squash, instead of taking supplements, to increase vitamin B6 intake.
Scientists Discover 1 Home Gadget That Can “Significantly Reduce” Your Blood Pressure. (Best Life)
(8/13) A study published in the Journal of the American College of Cardiology found that proximity to major roadways is linked to elevated blood pressure and using a HEPA filter removed dangerous PM 2.5 particles and led to a 3.0 mmHg drop in systolic blood pressure, with Jonathan Newman, MD, MPH, associate professor, Department of Medicine, the Leon H. Charney Division of Cardiology, Center for the Prevention of Cardiovascular Disease saying, “Overwhelming evidence shows the harmful health effects of PM2.5 exposure, even at levels below current U.S. standards,” and adding, “As healthcare professionals, we must educate the public and support policies that protect clean air and improve the health of all Americans.”
Why Are We Protecting Dogs But Not Humans Against Epidemic Lyme Disease? (Newsday (NY))
(8/13) In a guest essay, Arthur L. Caplan, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics, Department of Population Health, Division of Medical Ethics, advocates for prioritizing human Lyme disease vaccine development, referencing the existing canine vaccine, saying, “As tick-borne illnesses explode,” HHS Secretary Robert F. Kennedy Jr. “should demand that GlaxoSmithKline, which still holds the license for the 1998 LYMErix human vaccine, be made available on an emergency basis.”
Too Sick To Work? Consider The Patients, Says Ethicist. (Medscape)
ʲɲ* (8/13)* In a commentary, Arthur L. Caplan, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics, Department of Population Health, Division of Medical Ethics, highlighted the ethical dilemma faced by physicians working while sick, saying, “we have to think carefully about if I am compromising the patients’ interests” adding, that is “the circumstance under which maybe staying home might be best.”
News from NYU Langone Hospital—Brooklyn
The Surprising Ways Your Brain Changes (Good And Bad!) When Your Kids Leave Home. (Flowspace)
(8/13) Research indicates that the transition to an “empty nest” can lead to changes in brain structure and function, with Meleen Chuang, MD, chief, and clinical associate professor, Department of Obstetrics and Gynecology, Women’s Health at the Family Health Centers—Brooklyn, explaining that “neurology research shows the hippocampus prefrontal cortex (PFC) reorganize and actually thins out during menopause from hormonal changes specifically decreasing estrogen and progesterone levels,” which can enhance neuroplasticity and cognitive functions.
